Steven Cohen Eton Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,500 shares of ETON stock, worth $30,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$30,359% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
14MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$57.7 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$39.3 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$23.8 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$22.3 Million0.0% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$14 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $512M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...